Ignite Creation Date:
2024-05-06 @ 2:15 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04268953
Status:
COMPLETED
Last Update Posted:
2020-07-08
First Post:
2020-02-12
Brief Title:
Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production
Sponsor:
Cerecin
Organization:
Cerecin
Study Overview
Official Title:
A Phase 1 Single-centre Multiple-dose Open-label Study to Assess the Safety Tolerability and Pharmacokinetics of the AC-SD-03 Formulation of Tricaprilin in Healthy Older Volunteers
Status:
COMPLETED
Status Verified Date:
2020-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase I single center open label multiple dose pharmacokinetic PK study recruiting healthy older subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None